Professor David Clifton leads the Computational Health Informatics (CHI) Lab. He is a Research Fellow of the Royal Academy of Engineering, Visiting Chair in AI for Healthcare at the University of Manchester, and a Fellow of Fudan University, China. He studied Information Engineering at Oxford's Department of Engineering Science, supervised by Professor Lionel Tarassenko CBE. His research focuses on 'AI for healthcare'. In 2018, the CHI Lab opened its second site, in Suzhou (China), with support from the Chinese government.
David is the Research Director of Sensyne Health plc, the UK’s first public company for "clinical AI", the CEO of which is Lord Drayson (previous UK Minister for Science), and which translates research from Clifton’s lab into healthcare practice.
He is a Grand Challenge awardee from the UK Engineering and Physical Sciences Research Council, which is an EPSRC Fellowship that provides long-term strategic support for nine "future leaders in healthcare."
Research in the Computational Health Information (CHI) Laboratory focuses on the development of real in-hospital and in-home systems for Aidriven interventions that are used in practice. Translation into the developing world is a parallel research theme.
The lab has a focus on non-imaging AI applications: time-series analysis, -omics data, and sensor informatics.
CHI Lab offers a wide range of complex, real-world projects in AI for healthcare.